Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.2150
+0.0110 (+5.39%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
109,097
Open
0.2100
Bid (Size)
0.2110 (10)
Ask (Size)
0.2199 (9)
Prev. Close
0.2040
Today's Range
0.2000 - 0.2200
52wk Range
0.1900 - 2.750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
Today 11:05 EDT
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024
April 23, 2024
Via
Investor Brand Network
Performance
YTD
-81.93%
-81.93%
1 Month
-42.67%
-42.67%
3 Month
-54.27%
-54.27%
6 Month
-89.14%
-89.14%
1 Year
-87.35%
-87.35%
More News
Read More
CNS Pharmaceuticals to Present at the LSX World Congress 2024
April 23, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted in Upcoming Virtual Investor Lunch Break Event
April 22, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 22, 2024
Via
Benzinga
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
April 21, 2024
Via
ACCESSWIRE
New Research Sheds Light on the Initial Stages of Brain Cancer Development
March 18, 2024
Via
Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients
April 15, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 08, 2024
Via
Benzinga
Researchers Link Hormone Treatments to Heightened Risk of Brain Tumors
April 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update
April 02, 2024
Via
Investor Brand Network
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023
April 01, 2024
Via
InvestorPlace
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
April 01, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals to Present at Two Investor Conferences in April
April 01, 2024
Via
ACCESSWIRE
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
March 18, 2024
Via
Investor Brand Network
Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer
February 26, 2024
Via
Investor Brand Network
Top 5 Health Care Stocks That Are Preparing To Pump In February
February 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 07, 2024
Via
Benzinga
Scientists Start Trialing First Blood Test Against Brain Cancer
February 05, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 30, 2024
Via
Benzinga
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 30, 2024
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing
January 30, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 30, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.